LINC02847

Across TCGA pan-cancer cohorts, LINC02847 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02847 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02847 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02847 expression acts as an unfavorable survival marker, although some lineages such as LIHC and UCS show a favorable association.

LUAD, THCA, and LGG are the cancer types where LINC02847 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.425	0.778	.006	69	view →
THCA	OS	Tertile	All	0.952	0.992	.001	66	view →
LGG	OS	Tertile	All	0.673	0.841	<.001	45	view →
READ	OS	Tertile	III,IV	0.296	0.826	<.001	45	view →
UCEC	DFS	Tertile	All	0.764	0.854	.006	42	view →
LIHC	OS	Quartile	II,III,IV	0.917	0.549	.012	30	view →
ACC	OS	Quartile	All	0.385	0.790	.006	28	view →
KIRC	DFS	Median	IV	0.263	0.597	.014	24	view →
SKCM	OS	Median	All	0.263	0.372	.008	11	view →
UVM	OS	Tertile	III,IV	0.194	0.697	.008	9	view →
GBM	OS	Median	All	0.231	0.391	.019	8	view →
UCS	OS	Median	All	0.490	0.220	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02847–LUAD (DFS)

Open the LUAD breakdown →